53,000-square-foot facility addresses unique demands of commercial-scale viral vector production
Press Release
COSTA MESA, Calif., June 21, 2022 /3BL Media/ - Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing services for biotechnology and pharmaceutical companies, and CRB recently highlighted the companies’ collaborative efforts that enabled the phase-one opening of its new purpose-built, 53,000-square-foot viral vector and CGMP facility in Costa Mesa, California, in only eight months.
CRB is celebrating Pride Month this month with our Out+Allies employee resource group - a few members pictured here. This group of LGBTQ+ employees and allies are committed to fostering a welcoming and inclusive workplace, providing visibility to the LGBTQ+ community, and promoting individual diversity and uniqueness.
Data-driven Horizons report reveals critical challenges as manufacturers meet rising – and discerning – consumer demand
Press Release
KANSAS CITY, Mo., May 17, 2022 /3BL Media/ - While many industries struggle with economic and market challenges, a new report from CRB finds that pet food manufacturers are racing to add capacity to meet consumer demand for high-quality products, driven by “the humanization of pet food.”
“We are seeing more often that management is driving the adoption of digitalization in new facilities. It is becoming a standard and expected part of facility design,” shares Yvonne Duckworth, PE, Digitalization Leader and Group Leader Associate, with Pharmaceutical Technology.
Featured in Pharmaceutical Technology's January 2022 Issue, CRB’s Christa Myers provides her insights from topics in our latest Horizons Life Sciences report including operation warp speed, project delivery strategy, and the digital future – all of which are helping bring lifesaving treatments and therapeutics to market.
To find out which trends and technologies are reshaping the pharma industry, read the full piece here.
Commercializing cell and gene therapies efficiently requires timely decisions about whether to engage a CDMO or develop internal manufacturing capacity. Sometimes the best solution is to do both.
Blog
Commercializing cell and gene therapies efficiently requires timely decisions about whether to engage a CDMO or develop internal manufacturing capacity. Sometimes the best solution is to do both.
Women who are part of CRB’s construction team build a better world for people by supporting our clients construct facilities that produce lifesaving treatments and food and beverage products. One week is not enough to celebrate the incredible achievements and impact that our women have made on CRB and the world.
This year, our Women at CRB employee resource group asked our women what inspires them, what motivated them to pursue a career in construction, and any advice that they would give to those looking into coming into the industry.
On this International Women's Day, we're reflecting back on what Sarah Lanning, Process Engineer II, said on stage at CRB's Annual Leadership Meeting earlier this month.
"Working in a male dominated industry can be an intimidating challenge as a young engineer, but the incredible teams at CRB and inspirational women leaders make it a much more approachable one. CRB builds teams built on a foundation of trust and collaboration that create an incredible support system for our women as we create the facilities of tomorrow!"
We invite everyone to embrace the positive influence and teachings from incredible individuals throughout history this Black History Month, and every month after!
